Enterprise Value
$11.70B$2.25B+23.81%
Summary
- Current Value
- As of today, MRNA enterprise value is $11.70B, up +23.81% on
- All-time High
- MRNA enterprise value is currently -93.78% below its historical high of $188.17B set on
- 1-Year High
- MRNA enterprise value reached a 1-year high of $11.70B on
- 1-Year Low
- MRNA enterprise value reached a 1-year low of $3.92B on
- 1-Year Change
- MRNA enterprise value is up +60.55% over the past 365 days
- Sector rank
- MRNA enterprise value is higher than 91.67% of companies in Healthcare sector
Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Enterprise Value | $11.70B | +23.8% | +51.2% | +75.4% | +51.0% | +60.5% | -82.1% | -74.0% | |
| Price | $39.60 | +17.0% | +34.4% | +48.1% | +34.3% | +12.7% | -79.4% | -68.1% | |
| PE Ratio | - | – | – | – | – | – | – | – | |
| TTM Revenue | $2.23B | -27.5% | – | -27.5% | – | -56.0% | -89.5% | +804.7% | |
| TTM EPS | -$8.06 | -7.3% | – | -7.3% | – | -38.4% | -129.2% | -397.1% | |
| Market Cap | $15B | +17.0% | +34.4% | +48.1% | +34.3% | +14.0% | -79.1% | -68.7% | |
| Quarterly Total Debt | $734.00M | -0.9% | – | -0.9% | – | -45.8% | -41.8% | +245.8% | |
| Quarterly Cash & Cash Equivalents | $4.51B | -12.2% | – | -12.2% | – | -34.4% | -46.0% | +37.5% | |
| EV/EBITDA | -3.60 | -24.1% | -51.3% | -75.6% | -51.3% | -67.4% | -153.9% | +94.2% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $11.70B | at high | |
| 3M | $11.70B | at high | |
| 6M | $11.70B | at high | |
| 1Y | $11.70B | at high | |
| 3Y | $67.15B | -82.6% | |
| 5Y | $188.17B | -93.8% | |
| All | $188.17B | -93.8% |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $7.74B | +51.2% | |
| 3M | $4.97B | +135.7% | |
| 6M | $4.76B | +146.0% | |
| 1Y | $3.92B | +198.9% | |
| 3Y | $3.92B | +198.9% | |
| 5Y | $3.92B | +198.9% | |
| All | $3.01B | +288.6% |
History
| Date | Value | Change |
|---|---|---|
| $11.70B | +51.0% | |
| $7.75B | -20.7% | |
| $9.77B | -68.1% | |
| $30.61B | -49.4% | |
| $60.45B | -34.7% |
| Date | Value | Change |
|---|---|---|
| $92.54B | +148.2% | |
| $37.29B | +564.2% | |
| $5.61B | +58.5% | |
| $3.54B | - |
FAQ
What is the current enterprise value of MRNA?
As of today, MRNA enterprise value is $11.70B
What is MRNA enterprise value 1-year high?
MRNA enterprise value reached a 1-year high of $11.70B on January 13, 2026
What is MRNA enterprise value 1-year low?
MRNA enterprise value reached a 1-year low of $3.92B on May 15, 2025
What is 1-year change in MRNA enterprise value?
MRNA enterprise value is up +60.55% year-over-year
What is 3-year change in MRNA enterprise value?
MRNA enterprise value is down -82.06% over the past 3 years
How far is MRNA enterprise value from its all-time high?
MRNA enterprise value is currently -93.78% below its historical high of $188.17B set on August 9, 2021
How does MRNA enterprise value rank versus sector peers?
MRNA enterprise value is higher than 91.67% of companies in Healthcare sector
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt −
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna